ABSTRACT
A cross various series, distal ACA aneurysms have represented 2 to 9.2% of all intracranial aneurysms [1] [2] [3] [4] [5] [6] and comprised only 4.4% of the aneurysms in the ISAT. 7 Bridging veins, attenuated arachnoid adhesions between the cingulate gyri, deep and narrow exposure of the interhemispheric fissure, adherence of the aneurysm dome to the parenchyma, high perioperative rupture rates, and difficulty in controlling the parent vessel have all been considered obstacles to the microsurgical management of these relatively uncommon lesions. [8] [9] [10] [11] Concomitantly, controlling the microcatheter in its distal vascular distribution and the small size of distal ACA aneurysms are difficulties associated with their endovascular treatment. 12, 13 We report our 8-year experience managing these lesions and compare our outcomes, focusing on periprocedural results, with those of recent endovascular series and with surgical series of patients with distal ACA aneurysms.
MATERIALS AND METHODS
The medical records of patients with distal ACA aneurysms treated with endovascular techniques at the Barrow Neurological Institute were reviewed retrospectively for rupture status, clinical presentation, radiographic features, endovascular management, time to treatment, occlusion and recurrence rates, complications, and outcome at last follow-up. A 100% occlusion of the aneurysmal sac was considered complete. Near-complete occlusion was used for aneurysms judged to be 90% or more occluded as previously reported. 14 We assessed functional outcome by using the GOS. A GOS Ն4 was considered favorable.
Analysis of Endovascular and Microsurgical Series of Distal ACA Aneurysms
We searched PubMed for endovascular and microsurgical series on both ruptured and unruptured distal ACA aneurysms containing well-reported patient data and detailed outcome assessments on the basis of either the GOS or the modified Rankin Scale. Surgical series that included lesions not managed with the operating microscope were excluded. We analyzed 6 series on the endovascular management of distal ACA aneurysms published since 2004 that had consistent and homogeneous results. 10, 13, [15] [16] [17] [18] When our series was added to these 6 reports, our assessment of the current status of endovascular coiling was based on 160 patients with distal ACA aneurysms ( Table 1) .
The functional status of patients in 4 large series of microsurgical management of distal ACA aneurysms 1, 2, 8, 19 was compared with those in the endovascular series (Table 2) .
RESULTS
Between November 2000 and December 2008, a total of 22 patients (14 women, 8 men; mean age, 58.4 Ϯ 13.3 years; age range, 32-87 years) with distal ACA aneurysms underwent endovascular coiling (Table 3) . Thirteen patients (59.1%) presented with subarachnoid hemorrhage attributable to aneurysms of the distal ACA. The mean age of patients with ruptured aneurysms was 56.3 Ϯ 14.0 years and that of patients with unruptured aneurysms was 61.3 Ϯ 12.2 years (Table 4) . The features of all aneurysms and associated aneurysms are shown in Table 5 . Results from previous endovascular and surgical series of distal ACA aneurysms are tabulated in Tables 1 and 2 , respectively.
Ruptured Aneurysms
All 13 ruptured distal ACA aneurysms (Figs 1 and 2) were coiled within the first 4 days of hospitalization at our institution; 84.6% were coiled within the first 48 hours. At the end of the procedure, complete occlusion was observed in 7 patients and near-complete occlusion in 6 patients ( Table 3 ). The mean length of hospitalization was 16.2 days (range, 4 -34 days). Follow-up was limited and was considered a weakness of the study; of the 8 patients with additional follow-up after discharge, 7 (87.5%) had a favorable outcome at their last clinical consultation. Patients were observed for a mean of 12.5 months (range, 0 -50 months).
Again, as for clinical follow-up, radiographic follow-up was limited, with angiography available for 7 patients, all of whom had a complete occlusion. Only 1 patient experienced a recurrence, which was discovered 4 months after treatment. The lesion was recoiled. A third intervention was necessary to address a second recurrence 3 years later. Follow-up angiography showed complete occlusion 1 year after that treatment. There were no cases of rebleeding in the limited follow-up period.
Unruptured Aneurysms
In 9 patients treated for unruptured aneurysms, complete occlusion was achieved in 4 patients (44.4%) and near-complete occlusion in 4 ( Table 4 ). The patients were hospitalized for a mean of 4.6 days (range, 1-26 days) and were observed for a mean of 18.4 months (range, 1.5-62 months). At discharge, 7 patients (77.8%) had a GOS score of 5. Of the 9 patients, 8 had a GOS score of 5 at their last follow-up consultation, which again was of limited duration. Angiographic follow up was limited and was available for 6 of the 9 patients. Five patients had completely occluded lesions; a sixth patient maintained a near-total occlusion. In 1 patient, aneurysm regrowth was observed on follow-up MR angiography 5 months after embolization (Fig 3) . The lesion was again coiled, and complete occlusion was observed during a 5-year follow-up period.
Predictors of Outcome
As would be expected, a high HH score at hospital admission was associated with a significantly poor clinical outcome (P ϭ .006, r ϭ Ϫ0.562). No correlation was found between overall outcome and other predictive variables, including age, aneurysm size, intracerebral hemorrhage, and associated aneurysms, though the overall outcome at last follow-up was of limited duration. Periprocedural outcomes were excellent and included only 1 retroperitoneal hematoma and 1 intraoperative rupture. Four patients required abciximab infusion for thrombus formation, which developed during the procedure.
DISCUSSION

Evolution of Endovascular Management of Distal ACA Aneurysms
In the 1990s, favorable results from centers experienced with microsurgical clipping, combined with the low incidence of distal aneurysm had a favorable GOS score, and the mortality rate was 7.7% (Table 2) . 1 Although our follow-up was limited, periprocedural occlusion rates in our series compare well against historical controls. Of 22 patients, 11 (50%) experienced complete occlusion and another 10 (45%) had near-complete occlusion. Furthermore, there were no periprocedural deaths and only 1 instance each of intraprocedural rupture and retroperitoneal hematoma formation. Thromboembolic events were treated successfully with abciximab infusion in 4 patients. Nguyen et al 17 pointed out the caveat that the rate of intraprocedural rupture was higher when these lesions were coiled, compared with coiled aneurysms located elsewhere. They reported 3 perforations in 25 patients undergoing endovascular management of distal ACA aneurysms and suggested that the small size and distal distribution of the aneurysms could explain the high rate of rupture. 17 Overall, in 7 endovascular series that enrolled 160 patients, including the current series, intraoperative rupture occurred in only 5.6%.
10,13,15-18
Recurrences
Nguyen et al 17 emphasized the recurrence rate of coiled distal ACA aneurysms, though the rate was not significantly higher than that for intracranial aneurysms coiled elsewhere. The cumulative rate of distal ACA aneurysm recurrence was 52.6%. A major recurrence, an event leading to retreatment, was observed in 21%. Pandey et al 16 reported an 18% recurrence rate at a mean follow-up of 16.5 months. In a similar circumstance, Waldenberger et al 15 identified a recurrence in 17.2% of patients at 6-month follow-up examination. Although it is difficult to draw strong conclusions on the basis of the length of follow up, we observed aneurysm regrowth in 2 patients (15.4%) at a mean follow-up of 15 months. Both of our patients underwent coiling again, and the aneurysms remained completely obliterated. At a mean follow-up of 12.3 months, Raymond et al 20 found recurrences in 33.6% of 381 intracranial aneurysms at various sites after endovascular treatment. They stressed that a main factor involved in recurrence, besides the initial occlusion rate and rupture, is the large size of an aneurysm (an infrequent feature of distal ACA aneurysms). 20 Furthermore, the ISAT showed that the clinical implications of recurrences are unknown. 23 An identical rebleed rate was found in 43 patients in a surgical series focusing specifically on distal ACA aneurysms. 2 In a large series of 262 clipped distal ACA aneurysms, the rebleeding rate was only 0.4%. 25 Although immediate complete occlusion with clipping occurs at an incredibly high rate, the rate of immediate occlusion with coiling, whether complete or near-complete, was more than 95% in this series and compared favorably with previous reports (Table 2) .
Clinical Outcomes in Endovascular and Microsurgical Series, Focusing on Distal ACA Aneurysms
In 1999, Vanninen et al 26 reported the first randomized prospective study comparing endovascular treatment of ruptured intracranial aneurysms with surgical clipping. A late analysis at 12 months showed no significant difference in the clinical outcomes of both groups managing ACA aneurysms, but the procedurerelated mortality rate was higher among patients undergoing surgical clipping. The endovascular group in the ISAT had better outcomes, even after 7 years of follow-up. 27 However, this finding could not be generalized to a specific type of aneurysm such as distal ACA aneurysms. 16, 28 Studies have shown that the admission HH grade is a significant predictor of poor clinical outcome. 8, 15, 16, 19, 29 Intracerebral hemorrhage on initial CT also predicted a poor outcome in patients undergoing either endovascular or microsurgical treatment of distal ACA aneurysms. 8, 15, 19 The large number of distal ACA aneurysms surgically managed by Lehecka et al 19 yielded a longer list of predictors. Intraventricular hemorrhage, severe preoperative hydrocephalus, age, and rebleeding before treatment were associated with unfavorable clinical outcomes in their series.
Periprocedural Morbidity and Mortality Rates
Endovascular management of ACA aneurysms was associated with a mean morbidity rate of 8.8% and ranged from 0%-17.2%. 10, 13, [15] [16] [17] [18] In 2 surgical series providing satisfactory data, the mean rate of morbidity among 405 patients was 14.3%. 2, 19 Finally, the mean mortality rate in patients with distal ACA aneurysms undergoing endovascular treatment was 8.8% in the assessed series, including ours, and ranged from 0%-20.7%. 10, 13, [15] [16] [17] [18] On analysis of only the cases of patients with ruptured aneurysms (n ϭ 124), the mortality rate for endovascular treatment reached 11.3%. Overall, in 7 endovascular series that enrolled 160 patients, including the current series, intraoperative rupture occurred in only 5.6%. 10, 13, [15] [16] [17] [18] 
CONCLUSIONS
In our series, the periprocedural morbidity and mortality rates were similar to the risk profile of other reported series and demonstrate that these aneurysms can be treated safely by endovascular means. Recent advances in endovascular devices and techniques have improved treatment outcomes of distal ACA aneurysms, as seen in our series, with a favorable safety profile on the basis of analysis of periprocedural treatment success and complication rates. 
